US/Silver Spring: Yamtun7, a Delray Beach, Florida establishment, recalls all current batch/lots of Poseidon Platinum 3500 Supplements from the American marketplace due to reported undeclared Sildenafil and Tadalafil, two FDA approved drugs for the treatment of Male Erectile Dysfunction (“ED”), Benign Prostatic Hyperplasia (“BPH”) and certain other medical conditions and in a class of drugs called Phosphodiesterase (“PDE-5”) Inhibitors with consequential risks of dangerous low blood pressure, injury and possible life-changing complications, all serious health and safety hazards.
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Dietary Supplement products are subject to this recall:
Filed under: Dietary Supplements, Drugs, Labeling or regulatory issues, Sildenafil, Tadalafil, US FDA | Tagged: Benign Prostatic Hyperplasia, Benign Prostatic Hyperplasia ("BPH"), Dietary Supplements, Male Erectile Dysfunction ("ED"), Poseidon, Poseidon Platinum 3500 Supplement, Recalls Direct RIN: 14435-2021, undeclared Sildenafil hazard, undeclared-Tadalafil-hazard, US FDA, US Food and Drug Administration | Leave a comment »